NeuroSense Therapeutics
Or Eisenberg is currently the Chief Financial Officer at NeuroSense Therapeutics. Prior to this role, Or was the owner of O. Eisenberg Accounting Ltd, providing CPA, accounting, and financial services to small and medium-sized businesses. Or has also held various CFO and controller positions at companies such as Wize Pharma and Katzir Fund. With a background in Economics and Accounting from the University of Haifa, Or also has experience in assurance services from Ernst & Young.
This person is not in any offices
NeuroSense Therapeutics
NeuroSense Therapeutics is a clinical stage drug development company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.